SCHEMBL30187294

SCHEMBL30187294

COc1c(F)cc(CNc2ncnc3c2oc2nnc(C)c(C)c23)cc1F

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 10/20 0.48
PDE5A O76074 7/20 0.41
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19741213 1.00 CHRM4 (0.48) CHRM4PDE5AKDM4EMEN1USP2
SCHEMBL19741439 0.87 CHRM4 (0.52) CHRM4PDE5AKDM4EMEN1USP2
SCHEMBL30193637 0.87 CHRM4 (0.52) CHRM4PDE5AKDM4EMEN1USP2
SCHEMBL19740749 0.84 CHRM4 (0.43) CHRM4KDM4EMEN1USP2ALDH1A1
SCHEMBL30193558 0.84 CHRM4 (0.43) CHRM4KDM4EMEN1USP2ALDH1A1
SCHEMBL19741011 0.83 THRB (0.55) CHRM4PDE5AKDM4EMEN1USP2
SCHEMBL30193492 0.83 THRB (0.55) CHRM4PDE5AKDM4EMEN1USP2
SCHEMBL30193739 0.79 CHRM4 (0.52) CHRM4
SCHEMBL19741022 0.79 CHRM4 (0.52) CHRM4
SCHEMBL19741047 0.76 CHRM4 (0.74) CHRM4KDM4EMEN1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109310668-B Positive allosteric modulators of muscarinic acetylcholine receptor M4 范德比尔特大学 2023-01-24 CN claimed
US-20250026764-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 UNIV VANDERBILT (US) 2025-01-23 US disclosed
US-20230348490-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-11-02 US disclosed
US-20230014109-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014109-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885PDE5A 567/4885KDM4E 894/4885
US-20230348490-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885PDE5A 567/4885KDM4E 894/4885
US-20250026764-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885PDE5A 567/4885KDM4E 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.